CANCER-ASSOCIATED ANOREXIA

Clinical trials for CANCER-ASSOCIATED ANOREXIA explained in plain language.

Never miss a new study

Get alerted when new CANCER-ASSOCIATED ANOREXIA trials appear

Sign up with your email to follow new studies for CANCER-ASSOCIATED ANOREXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Cancer drug repurposed to fight Treatment-Related weight loss

Symptom relief Recruiting now

This study is testing whether adding the medication olanzapine to standard care helps head and neck cancer patients maintain their weight and appetite during intense chemoradiation treatment. About 66 patients will be randomly assigned to receive either standard care alone or sta…

Matched conditions: CANCER-ASSOCIATED ANOREXIA

Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief

Last updated Mar 30, 2026 14:32 UTC

CANCER-ASSOCIATED ANOREXIA

Get alerted when new CANCER-ASSOCIATED ANOREXIA trials appear

Cancer drug repurposed to fight Treatment-Related weight loss